General Information of This Drug (ID: DMRI15Q)

Drug Name
ACE-536   DMRI15Q

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 3 [1]
------------------------------------------------------------------------------------
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelofibrosis DISIMP21 2A20.2 Phase 2 [1]
Anemia DISTVL0C 3A00-3A9Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02268409) ACE-536 Extension Study - Beta Thalassemia. U.S. National Institutes of Health.